Trade Akoya Biosciences, Inc. - AKYA CFD

Add to favourite

2.81

3.44%

View detailed chart

To be able to trade stocks like this, create an account and apply for a stock listing.

Create Account

Summary
Historical Data

Trading сonditions

Spread

0.05

Long position overnight fee

-0.026235%

Short position overnight fee

0.004012%

Overnight fee time

21:00 (UTC)

Min traded quantity

Currency

USD

Margin

5.00%

Stock exchange

United States of America

Commission on trade

Key Stats

Prev. Close	2.91
Open	2.87
1-Year Change	-33.41%
Day's Range	2.72 - 2.87

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Sep 13, 2024	2.91	0.11	3.93%	2.80	2.94	2.80
Sep 12, 2024	2.79	0.21	8.14%	2.58	2.86	2.54
Sep 11, 2024	2.60	0.01	0.39%	2.59	2.63	2.49
Sep 10, 2024	2.62	0.33	14.41%	2.29	2.67	2.27
Sep 9, 2024	2.37	0.02	0.85%	2.35	2.39	2.33
Sep 6, 2024	2.34	0.02	0.86%	2.32	2.39	2.30
Sep 5, 2024	2.35	0.01	0.43%	2.34	2.37	2.25
Sep 4, 2024	2.32	-0.02	-0.85%	2.34	2.38	2.28
Sep 3, 2024	2.35	-0.13	-5.24%	2.48	2.60	2.34
Aug 30, 2024	2.52	-0.08	-3.08%	2.60	2.67	2.44
Aug 29, 2024	2.61	0.02	0.77%	2.59	2.65	2.52
Aug 28, 2024	2.54	0.07	2.83%	2.47	2.56	2.39
Aug 27, 2024	2.45	0.02	0.82%	2.43	2.45	2.32
Aug 26, 2024	2.45	-0.09	-3.54%	2.54	2.62	2.44
Aug 23, 2024	2.55	0.23	9.91%	2.32	2.56	2.32
Aug 22, 2024	2.34	-0.01	-0.43%	2.35	2.41	2.31
Aug 21, 2024	2.38	-0.03	-1.24%	2.41	2.41	2.30
Aug 20, 2024	2.39	-0.07	-2.85%	2.46	2.51	2.33
Aug 19, 2024	2.42	0.13	5.68%	2.29	2.46	2.29
Aug 16, 2024	2.27	0.12	5.58%	2.15	2.28	2.10

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

Leverage

1:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Akoya Biosciences, Inc. Company profile

About Akoya Biosciences Inc

Akoya Biosciences, Inc. is a life sciences technology company. The Company deliveries spatial biology solutions, which is focused on transforming discovery and clinical research. Spatial biology technology enables academic and biopharma scientists to detect and map the distribution of cell types and biomarkers across whole tissue samples at single-cell resolution, enabling advancements in their understanding of disease progression and patient response to therapy. Through its PhenoCycler and and PhenoImager platform, reagents, software and services, it offers end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research. It provides PhenoImager HT, which is a digital pathology slide scanner featuring MOTiF whole-slide multispectral scanning of up to seven biomarkers with an 80-slide capacity. It offers contract research services laboratory, which is called as advanced biopharma solutions.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Akoya Biosciences Inc revenues increased 29% to $54.9M. Net loss applicable to common stockholders increased from $21.8M to $44.4M. Revenues reflect Consumables segment increase of 68% to $14.3M, Instruments segment increase of 21% to $28.7M, North America segment increase of 39% to $28M, EMEA segment increase of 21% to $14.4M. Higher net loss reflects Selling.

Industry:

Advanced Medical Equipment & Technology (NEC)

100 Campus Drive
6th Floor
MARLBOROUGH
MASSACHUSETTS 01762
US

News

FOMC Decision Preview

As the US Federal Reserve prepares for its most significant decision since ending the rate hike cycle in mid-2023, the balance of risks has shifted. With inflation stabilizing at 2.6% and rising unemployment at 4.2%, the FOMC faces increasing pressure to address employment concerns. Markets anticipate a rate cut, with debate on the extent of the reduction.

09:48, 16 September 2024

ECB Preview: cuts expected but the pace is uncertain

Markets expect the ECB to cut rates again in September, but how many more?

12:34, 11 September 2024

Market analysis: US CPI and PPI

Overview of upcoming US inflation data for August, with expectations for a year-over-year CPI drop to 2.6% and core CPI holding steady at 3.2%. Markets will also focus on U.S. PPI data, which is forecasted to show mild growth, reinforcing potential easing inflationary pressures.

07:56, 10 September 2024

Introducing Newsquawk: your new in-platform newsfeed

We are very excited to announce the launch of Newsquawk in the Capital.com platform and app. This new newsfeed is designed to help you get ahead with real-time headlines, personalised stories and in-depth reports – all available directly in the platform and app, where you need them.

14:09, 20 August 2024